Bisphosphonates and atypical femoral shaft fractures

New England Journal of Medicine

Volumn 365, Issue 4, 2011, Pages 377-

  Stevenson, John C ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ATYPICAL FEMORAL SHAFT FRACTURE; DRUG USE; FEMUR SHAFT FRACTURE; HORMONE SUBSTITUTION; HUMAN; LETTER; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 79960851901     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1106551     Document Type: Letter

References (4)

1. Schilcher J, Michae¨lsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 2011;364:1728-37.
2. Park-Wyllie LY, Mamdani MM, Juurlink DN, et al. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 2011;305:783-9.
3. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
4. Stevenson JC, Hodis HN, Pickar JH, Lobo RA. Coronary heart disease and menopause management: the swinging pendulum of HRT. Atherosclerosis 2009;207:336-40.